あなたはここにいる:ホーム > お知らせ
04
16
2020
On April 10th 2020, the Deputy Mayor of Shenzhen Municipal Government Nie Xinping and his team visited Medicilon for the research. Dr. Chunlin Chen, Founder & CEO of Medicilon, accompanied the research and report.
04
04
2020
A national mourning period was held on Saturday, this year’s Tomb Sweeping Day, to commemorate those who succumbed to COVID-19.
03
15
2020
On March 10, 2020, PA1010 tablets, which are independently developed by Zhejiang Bolaatu Medical Technology Co., Ltd, obtained the implied license for NMPA clinical trials. This is the first new drug declared by Bolaatu. PA1010 is a new class I drug for chronic hepatitis B (CHB).
02
26
2020
Guangzhou Magpie Pharmaceuticals announced the clinical trials of MN-08, a treatment for Idiopathic Pulmonary Artery Hypertension (IPAH). IPAH is a progressive disease that affects the precapillary pulmonary vasculature. IPAH is a rare and fatal disease which has a high mortality rate.
02
10
2020
In 2019, Medicilon has had an extraordinary year. The steadily developing Medicilon made a huge accumulation in 2019 and achieved a qualitative leap. Let us look back on the moments of glory and Extraordinary “2 0 1 9”.